Skip to product information
1 of 1

BT Lab

SKU:BT-MCA0664

HAUSP Monoclonal Antibody

HAUSP Monoclonal Antibody

Regular price $300.00 USD
Regular price Sale price $300.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Host
Ab type

The protein encoded by this gene belongs to the peptidase C19 family, which includes ubiquitinyl hydrolases. This protein deubiquitinates target proteins such as p53 (a tumor suppressor protein) and WASH (essential for endosomal protein recycling), and regulates their activities by counteracting the opposing ubiquitin ligase activity of proteins such as HDM2 and TRIM27, involved in the respective process. Mutations in this gene have been implicated in a neurodevelopmental disorder.

Introducing the HAUSP Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of molecular biology. This meticulously crafted antibody is meticulously engineered to target and inhibit the activity of the HAUSP protein, thereby offering unprecedented opportunities for scientific research and therapeutic applications.

The HAUSP Monoclonal Antibody boasts exceptional specificity and affinity, ensuring precise and efficient binding to the HAUSP protein. This enables researchers to explore the intricate mechanisms underlying cellular processes, such as protein degradation, DNA repair, and cell cycle regulation. By elucidating the role of HAUSP in these fundamental biological pathways, novel insights into disease progression and potential therapeutic interventions can be gained.

Furthermore, the HAUSP Monoclonal Antibody exhibits remarkable stability and reproducibility, guaranteeing consistent and reliable results across experiments. Its exceptional performance is attributed to the utilization of state-of-the-art manufacturing techniques and stringent quality control measures, ensuring the highest standards of purity, potency, and functionality.

In addition to its invaluable research applications, the HAUSP Monoclonal Antibody holds immense promise in the realm of therapeutics. By selectively inhibiting the HAUSP protein, this antibody opens up new avenues for the development of targeted therapies against various diseases, including cancer, neurodegenerative disorders, and viral infections. Its potential to modulate critical cellular processes implicated in disease pathogenesis positions it as a powerful tool in the pursuit of novel therapeutic interventions.

The HAUSP Monoclonal Antibody is offered in various formats, including purified, conjugated, and labeled options, catering to diverse experimental requirements. Its user-friendly nature and compatibility with a wide range of techniques, such as Western blotting, immunoprecipitation, and immunofluorescence, ensure seamless integration into existing laboratory workflows.

In summary, the HAUSP Monoclonal Antibody represents a groundbreaking advancement in the field of molecular biology, offering unparalleled precision, reliability, and versatility. Whether employed in fundamental research or therapeutic development, this antibody is poised to redefine scientific exploration and contribute to the advancement of human health.

View full details